Today: 19 May 2026
First Majestic Silver stock rises premarket as silver hits two-week high; dividend date looms
23 February 2026
1 min read

First Majestic Silver stock rises premarket as silver hits two-week high; dividend date looms

New York, Feb 23, 2026, 08:44 EST — Premarket

  • AG tacked on roughly 1% ahead of the open, following Friday’s strong surge.
  • Silver gains, boosted by safe-haven bids as tariff uncertainty lingers
  • Traders are again eyeing the company’s Feb. 27 dividend record date.

First Majestic Silver Corp (AG) inched up roughly 1% to $27.82 in premarket action Monday. Shares finished Friday’s session at $27.55, having climbed 11.2% during the day.

This month, silver miners have swung sharply—essentially behaving as high-beta plays on the metal itself—reacting fast to even minimal moves in rates or shifts in risk appetite. Once mills are in motion, a jolt in bullion prices can drive revenue changes that outpace any adjustment on the cost side.

Spot silver climbed to its highest level in over two weeks, boosted as the dollar slipped after the U.S. Supreme Court struck down former President Donald Trump’s broad tariffs. The ruling also appeared to drive some safe-haven demand. “Concerns or confusion … over the outlook for tariffs” played a role, said independent analyst Ross Norman. Reuters

Other names were up in early trading too. Pan American Silver (PAAS) gained roughly 0.9%, Hecla Mining (HL) advanced 2%, and Coeur Mining (CDE) picked up around 1.1%.

First Majestic shares shot higher late last week after the company reported fourth-quarter revenue of $463.9 million and adjusted earnings of 30 cents per share. Silver output hit a record, coming in at roughly 4.2 million ounces for the quarter. The miner’s all-in sustaining cost clocked in at $23.48 per silver-equivalent ounce. Directors approved a quarterly dividend of $0.0083 per share for investors on record as of Feb. 27.

H.C. Wainwright analyst Heiko F. Ihle bumped his price target up to $30 from the previous $24.50, keeping a “buy” rating, GuruFocus reported in a summary of his note. GuruFocus

First Majestic runs mines across Mexico and the U.S.—San Dimas, Santa Elena, La Encantada among them. It also holds a 70% interest in the Cerro Los Gatos joint venture, according to LSEG data cited on Reuters.

Leverage cuts both ways here. Silver dropping, the dollar bouncing back, or even higher costs when prices are already up—any of those can knock miners fast. Margins usually take the first punch when something goes wrong at a specific company.

Stock Market Today

  • Western Digital Leverages Post-Quantum Cryptography to Enhance AI Data Security
    May 19, 2026, 9:57 AM EDT. Western Digital Corporation (WDC) integrates post-quantum cryptography (PQC) into its Ultrastar UltraSMR hard drives to address future AI data security risks. The drives, undergoing qualification with hyperscale customers, embed PQC directly into storage firmware, enhancing protection against quantum-era threats by ensuring firmware integrity and secure key management. Using NIST-aligned ML-DSA-87 and RSA-3072 algorithms, WDC advances device-level trust with dual-signing strategies. This positions WDC ahead in quantum-resistant enterprise storage security. Competitor Seagate Technology (STX) continues focusing on durable, cost-efficient storage solutions amid rising AI data demands, while WDC's split into SanDisk aims to capitalize further on AI-driven markets.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on
Next Story

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on

Go toTop